Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Go back to Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 212.50 -8.33 (3.77%)
Previous Close $220.83    52 Week High $333.65 
Open $215.45    52 Week Low $223.02 
Day High $217.28    P/E 27.21 
Day Low $210.54    EPS $7.81 
Volume 617,826